| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9021963 | International Congress Series | 2005 | 5 Pages |
Abstract
In conclusion, the qualitative use of CnTI-SonoVue® technology has improved our confidence in excluding pelvic malignancy. Furthermore, the quantitative assessment seems to be a promising tool for a better distinction between malignant and benign adnexal tumors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Caroline Van Holsbeke, Dirk Timmerman,